PALI
PALISADE BIO, INC.Company Information
- Company Name
- PALISADE BIO, INC.
- CIK
- CIK0001357459
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- PALI: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2836
- SIC Description
- Biological Products, (No Diagnostic Substances)
- Ticker
- PALI
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-07-09
- Last sale
- 2026-07-07
- Shares purchased (TTM)
- 75,000
- Shares sold (TTM)
- 204,563
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 173,499,660
- Shares outstanding
- 211,381,969
- Ownership
- 82.08%
Earnings Market Reaction
- Filing date
- 2026-08-10
- Price on filing date
- —
- 1-month reaction
- -0.48%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 125 | 133 | 133 | 5 | 5 | 7 | 10 | 8 | 11 | 11 | 12 | 15 | ||||||
| Accounts Receivable Net Current | 1 | - | - | - | 0 | - | - | - | - | - | - | - | ||||||
| Prepaid Expense And Other Assets Current | 2 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Assets Current | 127 | 133 | 134 | 7 | 6 | 8 | 10 | 9 | 12 | 12 | 13 | 16 | ||||||
| Restricted Cash Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Property Plant And Equipment Net | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Right Of Use Asset | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Other Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | ||||||
| Assets | 127 | 133 | 134 | 7 | 7 | 8 | 11 | 9 | 13 | 13 | 14 | 17 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 2 | 3 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 1 | ||||||
| Accrued Liabilities Current | 3 | 3 | 2 | 1 | 2 | 2 | 1 | 2 | 2 | 2 | 1 | 1 | ||||||
| Employee Related Liabilities Current | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | ||||||
| Operating Lease Liability Current | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Accrued Insurance Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | ||||||
| Liabilities Current | 5 | 6 | 5 | 3 | 4 | 3 | 3 | 3 | 3 | 2 | 3 | 3 | ||||||
| Derivative Liabilities Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Liability Noncurrent | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Other Liabilities Noncurrent | - | - | - | 0 | - | - | - | - | - | - | - | - | ||||||
| Business Combination Contingent Consideration Liability Noncurrent | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities | 6 | 6 | 5 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 2 | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 293 | 288 | 281 | 147 | 144 | 143 | 143 | 139 | 139 | 135 | 133 | 133 | ||||||
| Stockholders Equity | 122 | 127 | 129 | 3 | 3 | 5 | 7 | 7 | 10 | 10 | 11 | 14 | ||||||
| Liabilities And Stockholders Equity | 127 | 133 | 134 | 7 | 7 | 8 | 11 | 9 | 13 | 13 | 14 | 17 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | ||||||
| Common Stock Shares Authorized | 450 | 300 | 300 | 280 | 280 | 280 | 280 | 280 | 280 | 280 | 280 | 280 | ||||||
| Common Stock Shares Issued | 174 | 167 | 159 | 9 | 5 | 4 | 3 | 1 | 1 | 1 | 1 | 1 | ||||||
| Shares Outstanding | 174 | 167 | 159 | 9 | 5 | 4 | 3 | 1 | 1 | 1 | 1 | 1 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialPALISADE BIO, INC. (PALI) — SEC Financial Statements & Analysis
PALISADE BIO, INC. (PALI) is a biological products, (no diagnostic substances) company, incorporated in DE. PALISADE BIO, INC. trades on Nasdaq as: PALI. PALISADE BIO, INC. (PALI)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-10. Based on that filing, PALISADE BIO, INC. carries a market cap of $441.79M, a P/E ratio of -13.83x, a P/B ratio of 3.63x, a P/S ratio of 883.58x, an enterprise value of $316.62M, and an EV/EBITDA multiple of -8.96x. On profitability, it posts an operating margin of -7069.80%, a net margin of -6388.20%, a Return on Equity (ROE) of -51.37%, a Return on Assets (ROA) of -47.68%, and a Return on Invested Capital (ROIC) of -312.93%. Per share, it reports EPS of $-0.15, diluted EPS of $-0.15, free cash flow per share of $-0.09, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -100.00% year-over-year, net income growth of 169.66% year-over-year, and EPS growth of -93.88% year-over-year. On the balance sheet, it maintains a current ratio of 24.26x, a quick ratio of 23.96x, working capital of $122.01M, a debt-to-equity ratio of 0.05x, a debt ratio of 0.04, an interest coverage ratio of -5891.50x, free cash flow of $-18.19M (TTM), and net debt of $-125.17M. Figures sourced from SEC EDGAR.
- Market Cap
- $441.79M
- P/E TTM
- -13.83x
- EPS TTM
- $-0.15
- P/B TTM
- 3.63x
- ROE TTM
- -51.37%
- ROA TTM
- -47.68%
- Debt To Equity
- 0.05x
- Free Cash Flow TTM
- $-18.19M
- Net Revenue TTM Growth 1Y
- -100.00%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is PALISADE BIO, INC. in?
PALISADE BIO, INC. (PALI) operates in the Biological Products, (No Diagnostic Substances) industry.
What exchange does PALI trade on?
PALISADE BIO, INC. (PALI) trades on the Nasdaq.
Where is PALISADE BIO, INC. incorporated?
PALISADE BIO, INC. is incorporated in DE.
When was PALISADE BIO, INC. (PALI)'s most recent SEC filing?
PALISADE BIO, INC. (PALI)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-10.
What is PALI's market cap?
PALISADE BIO, INC. (PALI) has a market capitalization of $441.79M as of 2026-06-30.
What is PALI's EPS (earnings per share)?
PALISADE BIO, INC. (PALI)'s trailing twelve month EPS is $-0.15 as of 2026-06-30.
What is PALI's ROE (return on equity)?
PALISADE BIO, INC. (PALI)'s trailing twelve month Return on Equity (ROE) is -51.37% as of 2026-06-30.
What is PALI's ROA (return on assets)?
PALISADE BIO, INC. (PALI)'s trailing twelve month Return on Assets (ROA) is -47.68% as of 2026-06-30.
What is PALI's ROIC (return on invested capital)?
PALISADE BIO, INC. (PALI)'s trailing twelve month Return on Invested Capital (ROIC) is -312.93% as of 2025-12-31.
What is PALI's EV/EBITDA?
PALISADE BIO, INC. (PALI)'s trailing twelve month EV/EBITDA is -8.96x as of 2026-06-30.